Matches in DBpedia 2015-04 for { <http://dbpedia.org/resource/Vedolizumab> ?p ?o }
Showing triples 1 to 64 of
64
with 100 triples per page.
- Vedolizumab abstract "Vedolizumab (trade name Entyvio) is a monoclonal antibody being developed by Millennium Pharmaceuticals, Inc (a subsidiary of Takeda Pharmaceuticals) for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1). Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity. It is marketed under the trade name Entyvio.".
- Vedolizumab atcPrefix "L04".
- Vedolizumab atcSuffix "AA33".
- Vedolizumab casNumber "943609-66-3".
- Vedolizumab fdaUniiCode "9RV78Q2002".
- Vedolizumab wikiPageID "19842110".
- Vedolizumab wikiPageRevisionID "632339592".
- Vedolizumab atcPrefix "L04".
- Vedolizumab atcSuffix "AA33".
- Vedolizumab c "6528".
- Vedolizumab casNumber "943609".
- Vedolizumab chemspiderid "NA".
- Vedolizumab h "10072".
- Vedolizumab hasPhotoCollection Vedolizumab.
- Vedolizumab legalUs "Rx-only".
- Vedolizumab mabType "mab".
- Vedolizumab molecularWeight "146.8".
- Vedolizumab n "1732".
- Vedolizumab o "2042".
- Vedolizumab pregnancyUs "B".
- Vedolizumab s "42".
- Vedolizumab source "zu".
- Vedolizumab target "Integrin α4β7".
- Vedolizumab tradename "Entyvio".
- Vedolizumab type "mab".
- Vedolizumab unii "9".
- Vedolizumab verifiedfields "changed".
- Vedolizumab verifiedrevid "470629476".
- Vedolizumab watchedfields "changed".
- Vedolizumab subject Category:Monoclonal_antibodies.
- Vedolizumab type Abstraction100002137.
- Vedolizumab type Antibody115027189.
- Vedolizumab type Chemical114806838.
- Vedolizumab type Compound114818238.
- Vedolizumab type Macromolecule114944888.
- Vedolizumab type Material114580897.
- Vedolizumab type Matter100020827.
- Vedolizumab type Molecule114682133.
- Vedolizumab type MonoclonalAntibodies.
- Vedolizumab type MonoclonalAntibody115029781.
- Vedolizumab type OrganicCompound114727670.
- Vedolizumab type Part113809207.
- Vedolizumab type PhysicalEntity100001930.
- Vedolizumab type Protein114728724.
- Vedolizumab type Relation100031921.
- Vedolizumab type Substance100019613.
- Vedolizumab type Thing100002452.
- Vedolizumab type Unit109465459.
- Vedolizumab type Drug.
- Vedolizumab type DrugProduct.
- Vedolizumab type Thing.
- Vedolizumab type Q8386.
- Vedolizumab comment "Vedolizumab (trade name Entyvio) is a monoclonal antibody being developed by Millennium Pharmaceuticals, Inc (a subsidiary of Takeda Pharmaceuticals) for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1). Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity. It is marketed under the trade name Entyvio.".
- Vedolizumab label "Vedolizumab".
- Vedolizumab label "Vedolizumab".
- Vedolizumab label "Vedolizumab".
- Vedolizumab sameAs Vedolizumab.
- Vedolizumab sameAs Vedolizumab.
- Vedolizumab sameAs m.04q0jnv.
- Vedolizumab sameAs Q7918002.
- Vedolizumab sameAs Q7918002.
- Vedolizumab sameAs Vedolizumab.
- Vedolizumab wasDerivedFrom Vedolizumab?oldid=632339592.
- Vedolizumab isPrimaryTopicOf Vedolizumab.